
Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case
Purdue Pharma is expected to forfeit $225 million to the US justice department as part of a criminal opioids case. This forfeiture is part of a settlement that will allow the company to resolve thousands of lawsuits related to the opioid crisis.






